FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI
- PMID: 17709506
- DOI: 10.4049/jimmunol.179.5.2918
FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI
Abstract
Neutrophil-mediated tumor cell lysis is more efficiently triggered by FcalphaRI (CD89), than by FcgammaRI (CD64). This difference is most evident in immature neutrophils in which FcgammaRI-mediated tumor cell lysis is absent. In this study, we show that FcR gamma-chain-dependent functions (such as Ab-dependent cellular cytotoxicity and respiratory burst), as well as signaling (calcium mobilization and MAPK phosphorylation), were potently triggered via FcalphaRI, but not via FcgammaRI, in immature neutrophils. Internalization, an FcR gamma-chain-independent function, was, however, effectively initiated via both receptors. These data suggest an impaired functional association between FcgammaRI and the FcR gamma-chain, which prompted us to perform coimmunoprecipitation experiments. As a weaker association was observed between FcgammaRI and FcR gamma-chain, compared with FcalphaRI and FcR gamma-chain, our data support that differences between FcalphaRI- and FcgammaRI-mediated functions are attributable to dissimilarities in association with the FcR gamma-chain.
Similar articles
-
Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.J Immunol. 2006 Mar 15;176(6):3603-10. doi: 10.4049/jimmunol.176.6.3603. J Immunol. 2006. PMID: 16517729
-
Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89).Cancer Res. 2001 May 15;61(10):4055-60. Cancer Res. 2001. PMID: 11358825
-
Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors.J Immunol. 2005 May 1;174(9):5472-80. doi: 10.4049/jimmunol.174.9.5472. J Immunol. 2005. PMID: 15843545
-
Fc receptor inside-out signaling and possible impact on antibody therapy.Immunol Rev. 2015 Nov;268(1):74-87. doi: 10.1111/imr.12332. Immunol Rev. 2015. PMID: 26497514 Review.
-
IgA Fc receptors.Annu Rev Immunol. 2003;21:177-204. doi: 10.1146/annurev.immunol.21.120601.141011. Epub 2001 Dec 19. Annu Rev Immunol. 2003. PMID: 12524384 Review.
Cited by
-
Neutrophils in Cancer: Two Sides of the Same Coin.J Immunol Res. 2015;2015:983698. doi: 10.1155/2015/983698. Epub 2015 Dec 24. J Immunol Res. 2015. PMID: 26819959 Free PMC article. Review.
-
IgA EGFR antibodies mediate tumour killing in vivo.EMBO Mol Med. 2013 Aug;5(8):1213-26. doi: 10.1002/emmm.201201929. EMBO Mol Med. 2013. PMID: 23918228 Free PMC article.
-
Novel antibody-based proteins for cancer immunotherapy.Cancers (Basel). 2011 Aug 19;3(3):3370-93. doi: 10.3390/cancers3033370. Cancers (Basel). 2011. PMID: 24212958 Free PMC article.
-
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.Cancer Immunol Immunother. 2024 Oct 3;73(12):238. doi: 10.1007/s00262-024-03824-0. Cancer Immunol Immunother. 2024. PMID: 39358557 Free PMC article.
-
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.J Biol Chem. 2012 Jul 20;287(30):25139-50. doi: 10.1074/jbc.M112.353060. Epub 2012 Jun 7. J Biol Chem. 2012. PMID: 22679018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials